Skip to Main Content
Skip Nav Destination


Ibrutinib

Basics

Name

Ibrutinib

Special Alerts

Imbruvica Withdrawal of Mantle Cell Lymphoma and Marginal Zone Lymphoma IndicationsApril 2023

AbbVie announced on April 6, 2023, the intent to voluntarily wit...

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal